Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

BICEPS Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease

Coordinator
Rijksuniversiteit Groningen, Netherlands
Runs
1 November 2024 to 31 October 2028
Status
Running
EU funding
€3.9m
Total cost
—
Partners
17 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101167843

What the project is doing

In the project's own words, from its summary on CORDIS.

Decades of research into Parkinson's disease (PD) have fallen short in fully comprehending its mechanisms, leaving us without a cure. Current treatments merely alleviate symptoms temporarily, but are unable to impede the progression of the disease. Clearly, PD research has hit a wall, and new approaches are needed. Recent discoveries of the involvement of the peripheral immune system in PD have sparked a groundbreaking proposition by BICEPS: PD must be considered a systemic disease with an immune response involving both brain and periphery.

Thus, to revolutionize PD research, we must shift away from the neuro-centric approach of past decades and extend our focus to studying the immune system outside the brain. Furthermore, recent advancements, such as systems biology and artificial intelligence (AI)-driven data mining, diagnosis, and drug development, hold significant promise for advancing PD research. Therefore, BICEPS is uniting PD researchers, immunologists, and experts in AI and systems biology from leading European academic institutions, startup companies, and established pharmaceutical firms into a unique consortium.

The primary objective is to train a new generation of PD researchers with interdisciplinary expertise in these fields. This ambitious goal will be realized through an intensive training program that encompasses cutting-edge methodologies, encourages innovation, nurtures transferable skills, and provides immersive, hands-on research experiences. Thereby, the BICEPS network aims to shape the future of PD research by adopting a fresh perspective and expediting the development of diagnostics and therapies for PD, with a particular focus on the immune system.

Topics

Who is involved

OrganisationCityCountryRole
Rijksuniversiteit GroningenGroningenNetherlandsCoordinator
Association Europeenne Pour La Maladie De ParkinsonBruxelles / BrusselBelgiumAssociatedpartner
Bayer AktiengesellschaftLeverkusenGermanyParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyAssociatedpartner
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyParticipant
Freie Universitaet BerlinBerlinGermanyAssociatedpartner
Metasysx GmbHPotsdamGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
H. Lundbeck ASValbyDenmarkParticipant
Anacalypsis Therapeutics Idiotiki Kefalaiouchiki EtaireiaMoschatoGreeceParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Sulfateq B.v.GroningenNetherlandsParticipant
Faculty of Medicine, University of BelgradeBelgradeSerbiaParticipant
Suleyman Demirel UniversityIspartaTürkiyeAssociatedpartner
Semikal Teknoloji Sanayi ve Tic. Ltd. Sti.IspartaTürkiyeAssociatedpartner
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI